AI'sbioterrorism potential should not be ruled out - Financial Times
Just as we do not permit drug companies to rule on the safety of medicines,AI riskevaluation cannot be left to the industry alone. The OpenAI …
Read the original at Financial Times ↗
- Topics
- Banking & FinanceAI Safety & Existential RiskMarkets & Investment
- Mentions
- OpenAI
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”